fluoxetine has been researched along with Complications of Diabetes Mellitus in 3 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluoxetine has shown superior efficacy compared with placebo in the treatment of depression in patients with HIV/AIDS, diabetes mellitus or stroke; however, it has not significantly improved depressive symptoms versus placebo in patients with cancer." | 8.81 | Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness. ( Cheer, SM; Goa, KL, 2001) |
| "Fluoxetine has shown superior efficacy compared with placebo in the treatment of depression in patients with HIV/AIDS, diabetes mellitus or stroke; however, it has not significantly improved depressive symptoms versus placebo in patients with cancer." | 4.81 | Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness. ( Cheer, SM; Goa, KL, 2001) |
| "In comorbid diabetes mellitus and depression, most evidence supports the use of fluoxetine in control of glucose handling." | 4.81 | Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. ( Goodnick, PJ, 2001) |
| "In total, 3252 Chronic Renal Insufficiency Cohort participants with at least one study electrocardiogram between 2003 and 2011 were included." | 1.46 | Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations. ( Delafontaine, P; Deo, R; Doerfler, RM; Fink, JC; Fischer, MJ; Jaar, BG; Kramlik, S; Makos, GK; Navaneethan, S; Ojo, A; Slaven, A; Snitker, S; Soliman, EZ; St Peter, WL; Weir, MR; Zhan, M, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Snitker, S | 1 |
| Doerfler, RM | 1 |
| Soliman, EZ | 1 |
| Deo, R | 1 |
| St Peter, WL | 1 |
| Kramlik, S | 1 |
| Fischer, MJ | 1 |
| Navaneethan, S | 1 |
| Delafontaine, P | 1 |
| Jaar, BG | 1 |
| Ojo, A | 1 |
| Makos, GK | 1 |
| Slaven, A | 1 |
| Weir, MR | 1 |
| Zhan, M | 1 |
| Fink, JC | 1 |
| Cheer, SM | 1 |
| Goa, KL | 1 |
| Goodnick, PJ | 1 |
2 reviews available for fluoxetine and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness.
Topics: Acquired Immunodeficiency Syndrome; Antidepressive Agents; Clinical Trials as Topic; Cytochrome P-45 | 2001 |
Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Blood Glucose; Clinical Trials as T | 2001 |
1 other study available for fluoxetine and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Antidepressive Agents, Second-Generation; Citalopram; Diab | 2017 |